Powered by

Dicerna Pharmaceuticals announces stock options at exercise price per share equal to USD11.77 under NASDAQ Listing Rule 5635

Jan 09, 2019 - Global Banking News

RNAi therapeutics company Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) on Tuesday reported inducement stock options to purchase a total of 182,000 common stock in accordance with NASDAQ listing Rule 5635

The company added that the stock options were granted to nine new employees at an exercise price per share equal to USD11.77, the fair market value on the grant date of 2 January 2019.

Subject to the new employees' continued service relationship with the company on each such date, these...